A study in the British Journal of Cancer assesses the cost-effectiveness of integrating AI into the UK breast cancer screening program alongside traditional mammography. The analysis evaluates the economic tradeoffs of AI-driven diagnostic workflows, focusing on whether added performance translates into favorable cost-benefit outcomes for the screening system.